002603.SZ
以岭药业
SZSE · Healthcare · C 制造业 · CN
CNY 15.84
−3.71%Margins
Gross margin
66.1%
EBITDA margin
28.4%
EBIT margin
21.8%
Net margin
17.3%
FCF margin
22.6%
12.0%
Return on equity
9.7%
Return on assets
15.1%
Return on invested capital
0.57x
Asset turnover
CNY 2.0B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026